Role of Mesenchymal Stem Cells in Cancer Cell-Based Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 252
Special Issue Editor
Interests: diabetes and diabetes complications; cancer; cardiovascular; peripheral artery disease (PAD); critical limb ischemia pathology (CLI); regulatory standards; clinical trials; advanced therapies; advanced therapies medicinal products (ATMP); stem cells; good manufacturing practice (GMP); quality assurance (QA); quality control (QC); molecular and cellular biology; epigenetics; microRNAs; exosomes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mesenchymal stem cells (MSCs) are among the most frequently used cell type for regenerative medicine. Many studies have shown the beneficial effects of MSC-based therapies to treat different pathologies, including neurological disorders, cardiac ischemia, diabetes, and bone and cartilage diseases. However, the therapeutic potential of MSCs in cancer is still controversial. While some studies indicate that MSCs may contribute to cancer pathogenesis, emerging data have reported suppressive effects of MSCs on cancer cells.
The aim of this Special Issue is to provide a platform for molecular mechanistic research on mesenchymal stem cells, with a particular emphasis on cell-based cancer therapy. We welcome your contributions of original studies and reviews based on molecular and cellular findings.
Dr. Abdelkrim Hmadcha
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
-
mesenchymal stromal cells
- cancer
- cell therapy
- T-cells
- CAR T-cells
- CRISPR/Cas9
- exosomes
- immunomodulation
- cancer immunotherapies
- chemotherapy
- radiotherapy
- theranostics
- homing
- anti-tumor
- pro-tumor
- drug delivery
